Genetic evidence supporting the causal link between optic neuritis and rheumatoid arthritis
DOI:
https://doi.org/10.62051/8typ8n07Keywords:
Rheumatoid Arthritis, Optic Neuritis, Genome-Wide Association Study, Causal relationship.Abstract
Background: Previous studies have observed an association between optic neuritis (ON) and rheumatoid arthritis (RA). However, the causal relationship between these two conditions remains ambiguous. This study aimed to explore the causal effect between ON and RA using Mendelian randomization (MR) analysis. Methods: Summary statistics for RA (14,361 RA cases and 43,923 healthy controls (HCs)) and ON (582 cases and 217,491 HCs) were obtained from an available meta-analysis of published genome-wide association studies (GWAS).Bidirectional MR was performed using inverse-variance weighting, MR-Egger regression, and weighted-median analysis. Additionally, sensitivity tests including the leave-one-out analysis, MR-PRESSO, and Cochran’s Q test were conducted to assess the robustness and validity of the results. Results: The presence of ON may increase the risk of RA by 5.1% genetically (OR = 1.051, 95%CI: 0.003-0.100; p = 0.039). Sensitivity analyses provided no indications of heterogeneity (Cochran’s Q = 3.173, p = 0.787) or pleiotropy (intercept of 0.015, p = 0.533). No strong evidence that RA had a causal effect on ON risk (OR = 0.937, 95%CI: 0.830-1.057; p = 0.292). Sensitivity analyses provided no indications of heterogeneity (Cochran’s Q = 100.438, p = 0.081) or pleiotropy (intercept of 0.028, p = 0.091). Conclusion: This study provides genetic evidence suggesting that ON may contribute to the development of RA. These findings have potential implications for the management of RA.
Downloads
References
[1] Huang J, Fu X, Chen X, Li Z, Huang Y, Liang C. Promising Therapeutic Targets for Treatment of Rheumatoid Arthritis Front Immunol. 2021;12:686155. doi:10.3389/fimmu.2021.686155
[2] Guo Q, Wang Y, Xu D, Nossent J, Pavlos NJ, Xu J. Rheumatoid arthritis: pathological mechanisms and modern pharmacologic therapies Bone Res. 2018;6:15. doi:10.1038/s41413-018-0016-9
[3] Safiri S, Kolahi AA, Hoy D, Smith E, Bettampadi D, Mansournia MA, et al. Global, regional and national burden of rheumatoid arthritis 1990-2017: a systematic analysis of the Global Burden of Disease study 2017 Ann Rheum Dis. 2019;78:1463-1471. doi:10.1136/annrheumdis-2019-215920
[4] Catrina AI, Joshua V, Klareskog L, Malmstrom V. Mechanisms involved in triggering rheumatoid arthritis Immunol Rev. 2016;269:162-174. doi:10.1111/imr.12379
[5] Chen C, Su L, Duan W, Zheng Y, Zhang D, Wang Y. Asthma and atopic dermatitis as risk factors for rheumatoid arthritis: a bidirectional mendelian randomization study BMC Med Genomics. 2023;16:41. doi:10.1186/s12920-023-01461-7
[6] Saitakis G, Chwalisz BK. Treatment and Relapse Prevention of Typical and Atypical Optic Neuritis Int J Mol Sci. 2022;23. doi:10.3390/ijms23179769
[7] Clark D, Kebede W, Eggenberger E. Optic neuritis Neurol Clin. 2010;28:573-580. doi:10.1016/j.ncl.2010.03.001
[8] Dermawan A, So K, Venugopal K, Picardo S. Infliximab-induced optic neuritis BMJ Case Rep. 2020;13. doi:10.1136/bcr-2020-236041
[9] Lin YC, Wang AG, Yen MY. Systemic lupus erythematosus-associated optic neuritis: clinical experience and literature review Acta Ophthalmol. 2009;87:204-210. doi:10.1111/j.1755-3768.2008.01193.x
[10] Ma KS, Lee CM, Chen PH, Yang Y, Dong YW, Wang YH, et al. Risk of Autoimmune Diseases Following Optic Neuritis: A Nationwide Population-Based Cohort Study Front Med (Lausanne). 2022;9:903608. doi:10.3389/fmed.2022.903608
[11] Xiang S, Wang R, Hua L, Song J, Qian S, Jin Y, et al. Assessment of Bidirectional Relationships between Mental Illness and Rheumatoid Arthritis: A Two-Sample Mendelian Randomization Study J Clin Med. 2023;12. doi:10.3390/jcm12030944
[12] Sekula P, Del Greco MF, Pattaro C, Kottgen A. Mendelian Randomization as an Approach to Assess Causality Using Observational Data J Am Soc Nephrol. 2016;27:3253-3265. doi:10.1681/ASN.2016010098
[13] Zhang G, Cai Y, Liang J, Zhang J, Jing Z, Lv L, et al. Causal relationships between rheumatism and dyslipidemia: A two-sample Mendelian randomization study Front Endocrinol (Lausanne). 2022;13:961505. doi:10.3389/fendo.2022.961505
[14] Lawlor DA, Harbord RM, Sterne JA, Timpson N, Davey Smith G. Mendelian randomization: using genes as instruments for making causal inferences in epidemiology Stat Med. 2008;27:1133-1163. doi:10.1002/sim.3034
[15] Okada Y, Wu D, Trynka G, Raj T, Terao C, Ikari K, et al. Genetics of rheumatoid arthritis contributes to biology and drug discovery Nature. 2014;506:376-381. doi:10.1038/nature12873
[16] Arnett FC, Edworthy SM, Bloch DA, McShane DJ, Fries JF, Cooper NS, et al. The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis Arthritis Rheum. 1988;31:315-324. doi:10.1002/art.1780310302
[17] Bowden J, Del Greco MF, Minelli C, Davey Smith G, Sheehan NA, Thompson JR. Assessing the suitability of summary data for two-sample Mendelian randomization analyses using MR-Egger regression: the role of the I2 statistic Int J Epidemiol. 2016;45:1961-1974. doi:10.1093/ije/dyw220
[18] Bowden J, Davey Smith G, Burgess S. Mendelian randomization with invalid instruments: effect estimation and bias detection through Egger regression Int J Epidemiol. 2015;44:512-525. doi:10.1093/ije/dyv080
[19] Burgess S, Bowden J, Fall T, Ingelsson E, Thompson SG. Sensitivity Analyses for Robust Causal Inference from Mendelian Randomization Analyses with Multiple Genetic Variants Epidemiology. 2017;28:30-42. doi:10.1097/EDE.0000000000000559
[20] Bowden J, Davey Smith G, Haycock PC, Burgess S. Consistent Estimation in Mendelian Randomization with Some Invalid Instruments Using a Weighted Median Estimator Genet Epidemiol. 2016;40:304-314. doi:10.1002/gepi.21965
[21] Verbanck M, Chen CY, Neale B, Do R. Detection of widespread horizontal pleiotropy in causal relationships inferred from Mendelian randomization between complex traits and diseases Nat Genet. 2018;50:693-698. doi:10.1038/s41588-018-0099-7
[22] Skrivankova VW, Richmond RC, Woolf BAR, Davies NM, Swanson SA, VanderWeele TJ, et al. Strengthening the reporting of observational studies in epidemiology using mendelian randomisation (STROBE-MR): explanation and elaboration BMJ. 2021;375:n2233. doi:10.1136/bmj.n2233
[23] Skrivankova VW, Richmond RC, Woolf BAR, Yarmolinsky J, Davies NM, Swanson SA, et al. Strengthening the Reporting of Observational Studies in Epidemiology Using Mendelian Randomization: The STROBE-MR Statement JAMA. 2021;326:1614-1621. doi:10.1001/jama.2021.18236
[24] Agildere AM, Tutar NU, Yucel E, Coskun M, Benli S, Aydin P. Pachymeningitis and optic neuritis in rheumatoid arthritis: MRI findings Br J Radiol. 1999;72:404-407. doi:10.1259/bjr.72.856.10474506
[25] Roed H, Frederiksen J, Langkilde A, Sorensen TL, Lauritzen M, Sellebjerg F. Systemic T-cell activation in acute clinically isolated optic neuritis J Neuroimmunol. 2005;162:165-172. doi:10.1016/j.jneuroim.2005.02.002
[26] Dammacco R, Guerriero S, Alessio G, Dammacco F. Natural and iatrogenic ocular manifestations of rheumatoid arthritis: a systematic review Int Ophthalmol. 2022;42:689-711. doi:10.1007/s10792-021-02058-8
Downloads
Published
Issue
Section
License
Copyright (c) 2025 Transactions on Materials, Biotechnology and Life Sciences
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
